홈
마켓
차트 & 아이디어
Algo
뉴스
Store
브로커
다운로드
경제 달력
트레이딩 시그널
웹터미널
검색
/
타입: @user, $symbol
검색
로그인
계정을 생성하십시오
한국어
English
Русский
中文
Español
Português
日本語
Deutsch
Français
Italiano
Türkçe
VTYX
#2090
Ventyx Biosciences, Inc. Common Stock
13.9
7
-0.07%
부문:
베이스:
수익 통화:
일일 변동 비율
년간 변동
일일 변동
-0.07%
월간 변동
-0.07%
6달 변화
+454.37%
년간 변동율
+837.58%
이전 종가
13.9
8
Open
13.9
7
Bid
Ask
Low
13.9
7
High
13.9
7
양
75
마켓
주식
헬스케어
VTYX
Open full chart
Financials
Overview
성명
Statistics
Dividends
Quarterly
Annual
Value
Q3, 24
Q4, 24
Q1, 25
Q2, 25
Q3, 25
TTM
Key stats
Total common shares outstanding
70.71 M
71.13 M
71.16 M
71.31 M
71.36 M
—
Valuation ratios
Enterprise value
92.38 M
128.51 M
53.76 M
120.3 M
189.96 M
492.53 M
Price to earnings ratio
-0.92
-1.11
-0.68
-1.32
-2.16
-5.27
Price to sales ratio
—
1 102.7
—
—
—
—
Price to cash flow ratio
-0.86
-1.15
-0.72
-1.4
-2.5
-5.77
Price to book ratio
0.12
0.59
0.08
0.15
0.25
1.06
Enterprise value to EBITDA ratio
—
—
—
—
—
—
Profitability ratios
Return on assets %
0.12
0.11
0.11
0.12
0.11
0.44
Return on equity %
0.13
0.12
0.12
0.13
0.12
0.48
Return on invested capital %
—
—
—
—
—
—
Gross margin %
—
100
—
—
—
—
Operating margin %
—
90.05 K
—
—
—
—
EBITDA margin %
—
—
—
—
—
—
Net margin %
—
81.53 K
—
—
—
—
Liquidity ratios
Quick ratio
—
—
—
—
—
—
Current ratio
23.52
17.97
19.57
19.12
17.86
74.53
Inventory turnover
—
—
—
—
—
—
Asset turnover
0
0
—
—
—
—
Solvency ratios
Debt to assets ratio
—
—
—
—
—
—
Debt to equity ratio
—
—
—
—
—
—
Long term debt to total assets ratio
—
—
—
—
—
—
Long term debt to total equity ratio
—
—
—
—
—
—
Per share metrics
Operating cash flow per share
0.5
0.34
0.36
0.3
0.25
1.25
EBIT per share
—
—
—
—
—
—
EBITDA per share
—
—
—
—
—
—
Total debt per share
—
—
—
—
—
—
Cash per share
3.89
3.69
3.22
2.93
2.7
12.55
Net current asset value per share
4.1
3.35
3.41
3.08
2.82
12.66
Tangible book value per share
3.94
3.71
3.26
2.94
2.68
12.59
Working capital per share
3.92
3.17
3.24
2.92
2.66
11.98
Book value per share
3.94
3.71
3.26
2.94
2.68
12.59
뉴스
Lilly Stock Jumps After Q4 Earnings Beat and Strong 2026 Guidance
일라이릴리 합병 앞두고 벤틱스, 임원진에 현금 보너스 승인
Ventyx Biosciences approves cash bonus awards for executives ahead of planned merger
Why Eli Lilly Is The IBD Stock Of The Day — Again — As Its Novo Nordisk Rivalry Deepens
일라이릴리, BMO캐피털 ’아웃퍼폼’ 투자의견 유지, 목표가 1,200달러
Dow Jones Retail Giant Amazon Stock Eyes Latest Buy Point
BioAge Rockets As It Takes On Eli Lilly's Takeover Play, Ventyx Bio
Eli Lilly Stock Broke Out Following Plan To Acquire Ventyx Biosciences
Stock Market Rallies Broadly To Highs; Nvidia, AMD, Bloom Energy In Focus: Weekly Review
Healthcare dealmakers head to San Francisco hoping for megamergers in 2026
Biotech Stocks' Dark Winter Is Over. What That Means For Investors.
Eli Lilly (LLY) Buys Ventyx Biosciences in $1.2 Billion Deal - TipRanks.com